Position
Optas, LLC in Thermo Fisher Scientific Inc.
Back to the book · All holders of TMO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$178.5K$579.45 → $491.53
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.14K | $1.24M | — | — | — | 0.2% |
| Q1 2026 | 2.03K | $997.8K | $491.53 | −$178.5K | −$66.1K | 0.2% |